Hidden driver of mortality. A new study makes an uncomfortable point very clear. Respiratory viruses are probably involved in far more deaths than we usually recognize in day-to-day clinical practice or in official cause-of-death statistics🧵
Across 4 influenza seasons, a respiratory virus was found post mortem in 36.4% of deceased people. Influenza alone was present in 11.0%. It was not just flu either - rhinoviruses, common human coronaviruses, and RSV were also frequent.
The most striking part is how much was missed before death. Among people with influenza detected post mortem, only 17% had been diagnosed with influenza while alive.
That matters because what gets recorded as cardiac death, respiratory failure, or general decline may, in many cases, have had a hidden viral trigger helping push a frail patient over the edge.
The study does not claim every virus detected was the direct cause of death - but it strongly suggests we are overlooking a major part of the story.
These viruses are not harmless background noise. They can worsen an already fragile situation, destabilize chronic illness, and become part of fatal outcomes even when they never make it into the headline diagnosis.
The signal was especially strong in long-term care facilities, where any respiratory virus was found in 52.3% of deceased residents!
That is exactly where transmission is easier, patients are more vulnerable, and missed infections can carry the heaviest consequences.
So ignoring such a high prevalence would be a mistake. These infections are being underdiagnosed in life and undercounted in death.
The practical takeaway is simple.
Test more, think of viral etiologies more often, and stop assuming that if a patient looks cardiac, pulmonary, or just frail, infection is no longer central to what is happening.
And this study comes from the pre-COVID era. Since then, SARS-CoV-2 arrived. More severe, poorly tested, devastating in care homes, and far too often met with delayed, limited, or badly implemented antiviral access.
If we were already underestimating how flu and other respiratory viruses contribute to fatal decline, COVID only made that blind spot bigger. We need better testing, earlier recognition, and much better treatment access for the people at highest risk.
Trobajo-Sanmartín at al., Prevalence of influenza and other respiratory viral infections in deceased persons: a population-based observational study over four influenza seasons. clinicalmicrobiologyandinfection.org/article/S1198-…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
A new paper looks at shared molecular mechanisms between COVID-19 and Parkinson’s disease. It does not show that COVID causes Parkinson’s.
What it does ask is whether the two conditions share biologically meaningful pathways🧵
The authors identified 77 overlapping differentially expressed genes across COVID-19 and Parkinson’s datasets. The main signal points to inflammation-related pathways plus signs of dopaminergic neuron dysfunction!
Their main candidate is CHI3L1. In the single-cell analysis, CHI3L1 was especially elevated in astrocytes from severe COVID-19 brain tissue, which led the authors to propose an astrocyte - CHI3L1 - neuroinflammation axis as one possible explanation for why infection might worsen neurological outcomes.
A new population based study from Stockholm sends a pretty troubling signal.
During follow-up, a cardiovascular event occurred in 20.6% of men and 18.2% of women with diagnosed long COVID.🧵
In the control group without long COVID, the numbers were much lower. 11.1% for men and 8.4% for women.
These were not mainly patients recovering from severe acute COVID or ICU stays. The study focused on non-hospitalized adults aged 18-65 with no prior cardiovascular disease!
A new 2026 paper looks at a possible mechanism behind rare myocarditis after COVID-19 mRNA vaccination.
Not vaccines broadly damage the heart.
More like
some people may be biologically more vulnerable than others🧵
The paper’s central idea is mitochondrial vulnerability.
In simple English
your mitochondria can seem mostly fine under normal conditions, but still handle stress badly when the system gets pushed.
That matters because this study is trying to explain a rare adverse event, not argue that this is happening across the whole population.
That distinction is everything.
This new important preprint study makes a strong mechanistic case that the SARS-CoV-2 E protein localizes to mitochondria and is linked to concrete mitochondrial dysfunction🧵
It pushes E beyond the idea of being just a structural protein involved in viral assembly. The paper suggests it may also directly disrupt host-cell function at the mitochondrial level.
The authors connect several findings into one coherent picture. Mitochondrial localization of E, reduced membrane potential, impaired respiration, increased ROS, and broad lipid/metabolic changes.
A bystander apoptosis. The study in Nature argues that Omicron can drive the death of nearby, uninfected T cells. This paper shows an HIV-like pattern of immunopathology.🧵
A new paper suggests something important about severe Omicron cases.
The damage may not come only from the cells the virus infects directly.
It may also come from the immune cells caught in the crossfire.
The study argues that Omicron can drive the death of nearby, uninfected T cells.
That matters, because T cells are central to immune defense.
So the story is bigger than how much virus is inside a given cell.
Why might insulin resistance go up after COVID? Probably not because of one single cause, but because of a whole network of inflammatory and metabolic changes. A new narrative review.🧵
Some people seem to have worse blood sugar control and higher insulin resistance after COVID. What this paper argues is interesting - it’s probably not one clean, simple mechanism. It’s more like a web of biological processes that can keep reinforcing each other.
The authors first separate acute COVID from the longer post-COVID phase. In the acute stage, part of the problem may be in the pancreas itself. SARS-CoV-2 may affect the cells that make insulin. But when symptoms linger, they argue insulin resistance becomes the bigger story.